The CEO Roundtable on Cancer and its independent, not-for-profit initiative, Project Data Sphere® LLC, are proud to announce the approval of new ICD-10-CM diagnosis codes for immune-related adverse events (irAEs) in the United States. These codes, set to be implemented [...]
The CEO Roundtable on Cancer has awarded its Robert A. Ingram Spirit of Health Award to Gail Stephens, vice president of Health and Life Sciences at SAS, for her commitment to the fight against cancer. The award was presented at [...]
The CEO Roundtable on Cancer has awarded its Robert A. Ingram Spirit of Health Award to Gail Stephens, vice president of Health and Life Sciences at SAS, for her commitment to the fight against cancer. The award was presented at [...]
The CEO Roundtable on Cancer hosted its inaugural Partnership Summit at the global headquarters of SAS in Cary, North Carolina on Feb. 29 and March 1. The summit, a gathering of cancer experts from industry, nonprofits, academia and government, [...]
The CEO Roundtable on Cancer has recognized Merck (known as MSD outside the United States and Canada), and Major General Elder Granger for their contributions to cancer research with the Spirit of Health Award. The Spirit of Health Award was [...]
(From left) Ann Vickery (Hogan Lovells), Gail Stephens (SAS) and Dr.Charles Hugh-Jones (Sanofi) Hogan Lovells, SAS and Sanofi contributed significant insight and expertise to make the Project Data Sphere® initiative a reality. The three organizations each played integral roles in creating the infrastructure [...]
(From left) Christopher A. Viehbacher, Névine Zariffa (AstraZeneca), Dr. Gregory Curt (AstraZeneca), Dr. Howard Scher (Memorial Sloan Kettering Cancer Center), Coach Mike Krzyzewski (Duke University Men’s Basketball) AstraZeneca was recognized for its role not only as a pioneering cancer [...]
Dr. Mace L. Rothenberg (Pfizer), Dr. Monica Bertagnolli (Alliance for Clinical Trials in Oncology), Dr. Daniel J. Sargent (Alliance for Clinical Trials in Oncology), Christopher A. Viehbacher (Immediate Past Chairman, CEO Roundtable on Cancer) The 2015 winners of [...]
Dr. Martin J. Murphy, Dr. James S. Marks, Executive Vice President, Robert Wood Johnson Foundation, and Robert A. Bradway. The Robert Wood Johnson Foundation was honored as the recipient of the 2016 Charles A. Sanders Life Sciences Award, which was accepted [...]
(From left) Dr. Martin J. Murphy, Dr. Sean Khozin, Robert A. Bradway. The United States Food and Drug Administration (FDA) Oncology Center of Excellence was honored as the recipient of the 2017 Charles A. Sanders Life Sciences Award, which [...]
Left Photo (from left) Dr. Martin Murphy and Jean Becker | Right Photo (from left) Phil Porter, Bob Bradway and Ken Lee The CEO Roundtable on Cancer Inc. honored Jean Becker, Ken Lee and Phil Porter, three leaders dedicated to cancer prevention and to speeding [...]
Left Photo (from left) Maggie Bush and Former President George H.W. Bush | Center Photo (from left) Angel Martin and Bob Bradway | Right Photo (from left) Ann and Martin Murphy The CEO Roundtable on Cancer recognized two individuals and [...]
The CEO Roundtable on Cancer has recognized the healthcare business of Merck KGaA, Darmstadt, Germany, operating as EMD Serono in the US and Canada, with the 2020 Charles A. Sanders Award for collaborative scientific research in cancer. “It is an honor for Merck KGaA, [...]
Robert A. Ingram Amgen and Chief Executive Officer Robert A. Bradway and former Glaxo Wellcome CEO Robert A. Ingram were recognized for their leadership with the 2021 Dr. Charles A. Sanders Award for collaborative scientific research in cancer. Bradway accepted [...]
Peter WT Pisters, MD The CEO Roundtable on Cancer has recognized the University of Texas MD Anderson Cancer Center with its 2022 Dr. Charles A. Sanders Award for collaborative scientific research in cancer. “I am humbled and incredibly grateful to [...]
The CEO Roundtable on Cancer (CEORT) announced today the appointment of Sean Khozin, MD, MPH, as its next chief executive officer. A distinguished leader with senior executive experience in government and the private sector, including pivotal roles at the U.S. [...]
The CEO Roundtable on Cancer announced today that the University of North Carolina Pembroke and the University of Texas Permian Basin have joined its Going for Gold initiative. Going for Gold extends the Roundtable’s CEO Cancer Gold Standard® employer accreditation to minority-serving universities that [...]
The CEO Roundtable on Cancer announced today that Peter Guenter has been unanimously elected to its Board of Directors. Guenter is a member of the Executive Board of Merck KGaA and CEO of Healthcare. He joined Merck in January 2021. [...]